Nature's Sunshine Products Inc (NATR): Operating Income
$24.74M
Year ended 2025-12-31
$29.32M
Trailing 12 months to 2026-06-30
+15.0%
3-year compound annual growth
+2.9%
5-year compound annual growth
+6.0%
10-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.74M | +23.1% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $20.09M | +7.2% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $18.75M | +15.3% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $16.26M | -53.1% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $34.67M | +61.4% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $21.48M | +33.2% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $16.12M | +201.3% | 2021-03-10, From 2019-01-01 |
| 2018-12-31 | $5.35M | +285.8% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $1.39M | -86.2% | 2019-03-08, From 2017-01-01 |
| 2016-12-31 | $10.04M | -27.6% | 2019-03-08, From 2016-01-01 |
| 2015-12-31 | $13.87M | -27.2% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $19.05M | -19.2% | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | $23.58M | -30.4% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $33.87M | +67.9% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $20.16M | +79.0% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $11.26M | -9.4% | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $12.43M | n/a | 2012-03-05, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $24.74M | +23.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$62.82M | n/m |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | -$523.41M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$229.43M | n/m |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | -$22.14M | n/m |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | -$39.16M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $163.75M | -1.9% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $44.69M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$40.98M | n/m |
Compare NATR, TVTX, BBIO, ZLAB side by side · Screen every company in Pharmaceutical Preparations ↗